On 16 September 2026, SBP GROUP (01177.HK) announced that the NDA for TQB2102 injection (a HER2 biparatopic bispecific ADC), a National Class 1 innovative drug independently developed by its subsidiary Chia Tai Tianqing, has been accepted for review by the CDE, for HER2-low breast cancer in adults.
On 15 September 2026, YUK WING GP (01536.HK) announced that controlling shareholder Choi Fai Investment disposed of an aggregate of 175,746,000 shares between 8 and 15 September 2026, representing approximately 38.54% of the Company's total issued share capital, and ceased to be a controlling and substantial shareholder.
On 16 September 2026, SF HOLDING (06936.HK) announced that the Company and the issuer entered into a subscription agreement to issue RMB 5 billion 1.75% guaranteed bonds due 2029 and RMB 5 billion 1.85% guaranteed bonds due 2031, with gross proceeds of approximately RMB 10 billion.
On 16 September 2026, TRIP.COM-S (09961.HK) announced its second quarter and first half results, with second quarter net revenue of RMB 15.7 billion, up 6% year on year, and a net loss of RMB 2.4 billion because of a RMB 5.2 billion antitrust penalty.
On 15 September 2026, DTECH (01377.HK) announced that the vesting conditions for the second vesting period of the reserved grant under its 2023 restricted share incentive scheme have been fulfilled, with 32 grantees able to vest 363,180 Class II restricted shares at a grant price of RMB 8.79 per share.
On 15 September 2026, CHIHO ENV (00976.HK) announced that it received a civil ruling from the Chongqing No. 5 Intermediate People's Court approving the withdrawal by the plaintiff, Mr. Li, of his claim against Chiho Tiandi Metal, a wholly-owned subsidiary of the Company.
On 15 September 2026, DTECH (01377.HK) announced that its wholly-owned subsidiary Dingtaixin will invest in and build an advanced new materials manufacturing base project in Houjie, Dongguan, with a total investment of RMB 700 million, including RMB 560 million of fixed asset investment.
On 15 September 2026, Suzhou Basecare Medical Corporation Limited (02170.HK) announced that the freezing solution kit and the thawing solution kit of its Gems vitrification series have recently obtained Class III medical device registration certificates issued by the National Medical Products Administration; the products originate from the same research and development system as the Gavi fully automated closed vitrification system.
On 15 September 2026, Jiangsu New Vision Automotive Electronics Co., Ltd. (02632.HK) announced that it is cooperating with Zhejiang University to develop ultra-high-precision computational holography key technology to develop a computer-generated holography (CGH) image generation solution for visual products and advance the application of CGH technology in visual products; the cooperation does not constitute a discloseable transaction or a connected transaction under Chapter 14 or Chapter 14A of the Listing Rules.
On 15 September 2026, PATEO CONNECT Technology (Shanghai) Corporation (02889.HK) announced that Mr. Zhang Fukai, an executive director, chief financial officer and Board Secretary, and Mr. Lai Weilin, an executive director, increased their holdings of the Company's H shares on the open market with their own funds by 40,760 shares and 21,860 shares respectively, representing approximately 0.024% and approximately 0.013% of the total issued shares, for total consideration of approximately RMB 3.00 million and approximately RMB 1.60 million respectively.
On 15 September 2026, Cherish Sunshine International Limited (01094.HK) announced that Mr. Yang Hua has tendered his resignation as chief executive officer of the Group with effect from 15 September 2026, while remaining an executive director, joint chairman of the Board and an authorised representative of the Company under Rule 3.05 of the Listing Rules.
On 15 September 2026, Jolimark Holdings Limited (02028.HK) announced that the controlling shareholder completed a partial placing on that date, with the vendor placing an aggregate of 129,100,000 shares through the placing agent in accordance with the terms of the placing agreement; as the placing may or may not be carried out in full, shareholders and potential investors should exercise caution when dealing in the shares.
On 15 September 2026, CC SECURITIES (01375.HK) announced that it received notice from Zhongding Kaiyuan that Zhongding Kaiyuan had entered into a supplemental agreement with the other partners of the fund to amend and supplement the partnership agreement and had completed private investment fund filing with the Asset Management Association of China, with the fund named Henan Xiangding Digital Equity Investment Fund Partnership (Limited Partnership).
On 15 September 2026, JIAXIN INTL RES (03858.HK) announced that Mr. Liu Liqiang has tendered his resignation as chairman of the Board, executive director and a member of the Company's remuneration committee due to other business commitments, with effect from 15 September 2026.
On 15 September 2026, TIANJINJINRAN (01265.HK) announced that it received a resignation letter from Ms. Ji Xuefeng, who proposed to resign as an independent non-executive director as her personal official duties and full-time work commitments have become increasingly onerous, and will step down upon the election of a new independent non-executive director at a shareholders' meeting.
On 15 September 2026, KINGMAKER (01170.HK) announced that, on the recommendation of the remuneration committee, the Board resolved to grant a total of 1,292,000 award shares to 15 grantees under the share award scheme free of charge, representing approximately 0.19% of the Company's issued share capital as at the date of the announcement.
